Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Biosimilar”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT04321291
What this trial is testing

Information and Acceptability of Biosimilars

Who this might be right for
Rheumatoid ArthritisSpondyloarthritisPsoriatic Arthritis
University Hospital, Montpellier 500
Early research (Phase 1)Study completedNCT01534884
What this trial is testing

Demonstrate the Equivalence of CT-P10 to MabThera With Respect to the Pharmacokinetic Profile in Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Celltrion 154
Early research (Phase 1)Active Not RecruitingNCT06551064
What this trial is testing

Assessment of PK Similarity of FYB206 in Comparison With Keytruda in Resected Stage II or III Melanoma Patients

Who this might be right for
Melanoma, Stage IIMelanoma Stage III
Formycon AG 96
Early research (Phase 1)Study completedNCT04183491
What this trial is testing

Pharmacodynamic Biomarkers to Support Biosimilar Development: Interferon Beta-1A Products

Who this might be right for
Healthy SubjectsPharmacokineticsPharmacodynamics
Food and Drug Administration (FDA) 84
Early research (Phase 1)Study completedNCT06392074
What this trial is testing

A Study Investigating the Safety, Absorption, and Elimination of MB04, a New Compound That May Potentially be Used in the Treatment of Autoimmune Disorders

Who this might be right for
Healthy Volunteers
mAbxience Research S.L. 141
Large-scale testing (Phase 3)Study completedNCT04361279
What this trial is testing

A Study Comparing SIBP-02 and Rituximab Combination With CHOP in Previously Untreated Subjects With CD20+ DLBCL

Who this might be right for
Diffuse Large B-Cell Lymphoma
Shanghai Institute Of Biological Products 421
Early research (Phase 1)Study completedNCT02912377
What this trial is testing

Immunogenicity and Pharmacodynamic of B12019 and Neulasta® in Healthy Subjects

Who this might be right for
Healthy Volunteers
Cinfa Biotech 96
Early research (Phase 1)Study completedNCT03357939
What this trial is testing

Phase I Study of HLX3 vs Adalimumab in Chinese Healthy Subjects

Who this might be right for
Immune System Disorder
Shanghai Henlius Biotech 220
Early research (Phase 1)Study completedNCT06488521
What this trial is testing

A Safety and Pharmacokinetics Study of Complarate (Tocilizumab Biosimilar Solution) and Actemra® in Healthy Volunteers

Who this might be right for
Healthy Volunteers
AO GENERIUM 256
Testing effectiveness (Phase 2)UnknownNCT05355155
What this trial is testing

Bevacizumab Biosimilar Plus FOLFOX4 in the Treatment of Recurrent HCC After Liver Transplantation

Who this might be right for
Post-orthotopic Liver TransplantationHepatocellular Carcinoma Recurrent
The First Affiliated Hospital with Nanjing Medical University 15
Not applicableUnknownNCT03192878
What this trial is testing

Infliximab Biosimilar in Takayasu's Arteritis

Who this might be right for
Takayasu Arteritis
Ospedale San Raffaele 30
Early research (Phase 1)Ended earlyNCT01534949
What this trial is testing

Provide Initial Evidence of Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy to Support the Pivotal CT-P10 Therapeutic Equivalence Trial

Who this might be right for
Diffuse Large B-Cell Lymphoma
Celltrion 1
Not applicableLooking for participantsNCT06997055
What this trial is testing

ROLL'YN-UST: an Observational Study in Patients Treated by Steqeyma®, an Ustekinumab Biosimilar

Who this might be right for
Crohn DiseasePlaque Psoriasis
Celltrion HealthCare France 225
Early research (Phase 1)Study completedNCT06481189
What this trial is testing

A Safety, Pharmacokinetics and Pharmacodynamics Study of GNR-086 and Ilaris® in Healthy Volunteers

Who this might be right for
Healthy Volunteers
AO GENERIUM 105
Early research (Phase 1)Study completedNCT05245669
What this trial is testing

Study to Compare the Pharmacokinetics, Pharmacodynamics, Safety, Tolerability, and Immunogenicity of Biosimilar Denosumab With Prolia® in Healthy Adult Male Volunteers

Who this might be right for
Healthy Male Subjects
Enzene Biosciences Ltd. 207
Not applicableStudy completedNCT07235527
What this trial is testing

Real-Life Clinical Outcomes of Aflibercept Biosimilar MY-1701P in the Treatment of Exudative Age-Related Macular Degeneration

Who this might be right for
Age Related Macular DegenerationExudative Age-Related Macular DegenerationAnti Vascular Endothelial Growth Factor
Saglik Bilimleri Universitesi 54
Large-scale testing (Phase 3)Study completedNCT02714322
What this trial is testing

MYL-1401A Efficacy and Safety Comparability Study to Humira®

Who this might be right for
PsoriasisArthritis, Psoriatic
Mylan Inc. 294
Not applicableLooking for participantsNCT01848028
What this trial is testing

PsoBest - The German Psoriasis Registry

Who this might be right for
PsoriasisPsoriatic-arthritis
Universitätsklinikum Hamburg-Eppendorf 3,500
Testing effectiveness (Phase 2)UnknownNCT04591457
What this trial is testing

The Efficacy, Safety, and Immunogenicity Study Comparing an Insulin Glargine Biosimilar Sansulin Log-G to Lantus

Who this might be right for
Diabetes Mellitus
Universitas Indonesia 120
Early research (Phase 1)Study completedNCT06153238
What this trial is testing

A PK Study to Compare GME751 (Proposed Pembrolizumab Biosimilar) and US-licensed and EU-authorized Keytruda® in Participants With Stage II and III Melanoma

Who this might be right for
Melanoma
Sandoz 322
Next Page